Craig-Hallum Reaffirms Their Buy Rating on Xtant Medical Holdings (XTNT)
Xtant Medical Announces Launch of SimpliGraft and SimpliMax for Chronic and Acute Wounds
BELGRADE, Mont., April 30, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2023 Earnings Call Transcript
Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT), Liquidia Technologies (LQDA) and Xtant Medical Holdings (XTNT)
Xtant Medical's Earnings at Risk: The Unhedged Perils of Currency Fluctuations
Q4 2023 Xtant Medical Holdings Inc Earnings Call
Xtant Medical Files $150 Million Mixed Shelf; Shares Fall
Xtant Medical Holdings (XTNT) shares fell almost 12% in recent Monday trading after the company filed a registration statement with the US Securities and Exchange Commission covering the potential sal
Xtant Medical Shares Drop 11% Following Wider 4Q Loss
By Sabela Ojea Shares of Xtant Medical on Monday after the company logged a wider loss for the fourth quarter despite seeing significant revenue growth for the period. In recent trading, shares were
Earnings Call Summary | Xtant Medical(XTNT.US) Q4 2023 Earnings Conference
The following is a summary of the Xtant Medical Holdings Inc. (XTNT) Q4 2023 Earnings Call Transcript:Financial Performance:Xtant Medical Holdings saw Q4 revenue of $28.1 million, an 84% increase year
Xtant Medical Holdings (XTNT) Receives a Buy From Craig-Hallum
Xtant Medical Holdings Inc (XTNT) Reports Record Revenue in 2023, Outpacing Analyst Estimates
Xtant Medical Holdings Inc Files For Mixed Shelf Offering Of Up To $150M
Xtant Medical Holdings Inc Files For Mixed Shelf Offering Of Up To $150M
Xtant Medical Expects FY2024 Sales Of $112M-$116M Versus Consensus Of $115.95M
Xtant Medical Expects FY2024 Sales Of $112M-$116M Versus Consensus Of $115.95M
Xtant Medical Q4 GAAP EPS $(0.03) Misses $(0.02) Estimate, Sales $28.11M Beat $26.55M Estimate
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent decrease over losses of $(0.02
Earnings Flash (XTNT) XTANT MEDICAL Reports Q4 Revenue $28.1M
07:01 AM EDT, 04/01/2024 (MT Newswires) -- Earnings Flash (XTNT) XTANT MEDICAL Reports Q4 Revenue $28.1M
Xtant Medical Holdings 4Q Loss $4.3M >XTNT
Xtant Medical Holdings 4Q Loss $4.3M >XTNT
Press Release: Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million Establishes Full Year 2024 Revenue Guidance of $112 Million - $116 Million BELGRADE, Mont., April 01, 2024 (GLOBE NEWSWIRE) --
Analysts Are Bullish on These Healthcare Stocks: Trulieve Cannabis (TCNNF), Xtant Medical Holdings (XTNT)
Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024
BELGRADE, Mont., March 21, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced
Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Xtant Medical Holdings (XTNT) and Oncternal Therapeutics (ONCT)
No Data